申请人:Promentis Pharmaceuticals, Inc.
公开号:EP2937334A1
公开(公告)日:2015-10-28
The invention relates to compounds of formula II, pharmaceutical compositions containing these compounds, and methods of using these compounds for the treatment of various diseases or conditions, including but not limited to diseases and/or conditions of Central Nervous System (CNS).
本发明涉及式 II 的化合物、含有这些化合物的药物组合物以及使用这些化合物治疗各种疾病或病症的方法,包括但不限于中枢神经系统(CNS)的疾病和/或病症。